Vojtěch Viktorin is a clinical psychologist and psychotherapist based in Prague. He co-founded Czech Psychedelic Society in 2015, he actively participates as a researcher and therapist in clinical trials involving psilocybin, ketamine, and MDMA at National Institute of Mental Health. Currently pursuing a Ph.D. in neuroscience, his research focuses on psilocybin's impact on depression. Working at first czech psychedelic clinic Psyon, he conducts ketamine-assisted psychotherapy.